Pharmaceutical Technology
The leading site for news and procurement in the pharmaceutical industry
- Website
- pharmaceutical-technology.com · all feeds from this site
- Feed URL
https://www.pharmaceutical-technology.com/feed/
Read it in your FeedListing reader
Or add to: Feedly Inoreader Raw feed
Latest posts
-
Pelthos and Castle Creek plan merger to target skin diseases
Pelthos Therapeutics has agreed to merge with Castle Creek Biosciences to form a new biotechnology company that will focus on serious diseases affecting the skin.
-
Inovio’s Voceryq receives FDA accelerated approval for RRP
Inovio has secured accelerated approval from the FDA for Voceryq to minimise the frequency of surgery in adults with recurrent respiratory papillomatosis (RRP).
-
IDWeek 2026: early ensitrelvir PEP may benefit breakthrough and established Covid-19
At IDWeek 2026, Akimasa Fukushi from Shionogi presented a subpopulation analysis of the Phase III SCORPIO-PEP trial.
-
IDWeek 2026: ISL/LEN on track to become the first once-weekly oral HIV therapy
At IDWeek 2026, Samir K Gupta presented a pooled analysis of the Phase III ISLEND-1 and ISLEND-2 trials evaluating once-weekly ISL/LEN in adults with virologically suppressed HIV.
-
Prediction markets herald insider trading risks for private biotechs
Legal experts say that pharma outcome bets on platforms like Kalshi and Polymarket pose new insider trading risks.
-
Casgevy gains UK label expansion for younger patient population
Following this MHRA label expansion, UK patients with β-thalassemia and sickle cell disease aged five and up can now receive Casgevy.
-
Eli Lilly’s tirzepatide outperforms big pharma companies in Q3
Sales for Eli Lilly’s Mounjaro and Zepbound topped $16bn, exceeding total revenue for many big pharma players.
-
Glenmark opens Allentown distribution hub in US
Glenmark Pharmaceuticals has inaugurated an approximately 160,000ft² distribution hub in Allentown, Pennsylvania, US.
-
Dren Bio raises $350m for dibotatug clinical development
Dren Bio has secured $350m in an oversubscribed private financing round to advance its primary investigational therapy, dibotatug, through late-stage clinical evaluation, regulatory submission, and potential commercialisation.
-
RFK Jr backs compounding of six unapproved peptides in new policy
The policy will allow licensed professionals to use certain wellness-focused peptides not approved by the FDA in their compounded medicines.
-
Gaelic Labs: the EU Critical Medicines Act will have a positive impact on supply
Gaelic Labs is eyeing competitive benefits from its 2025 acquisition of fellow Irish beta-lactams manufacturer and further expansion.
-
IDWeek 2026: Abrysvo data in nursing home residents could support re-vaccination
Abrysvo was first approved in the US in 2023 for the prevention of lower respiratory tract disease (LRTD) caused by RSV.